EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies

Abstract

Our findings suggest that EZH2 protein, as examined by immunohistochemistry, may serve as a promising diagnostic biomarker of HCCs, and the use of a three-marker panel (EZH2, HSP70 and GPC3) can improve the rate of detection of HCCs in liver biopsy tissues.